X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (17) 17
male (14) 14
article (13) 13
female (13) 13
middle aged (12) 12
abridged index medicus (10) 10
vasculitis (10) 10
wegeners-granulomatosis (10) 10
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (9) 9
rheumatology (9) 9
rituximab (9) 9
adult (8) 8
aged (8) 8
remission induction (8) 8
cyclophosphamide - therapeutic use (7) 7
double-blind method (7) 7
treatment outcome (7) 7
immunologic factors - therapeutic use (6) 6
immunosuppression (6) 6
remission (6) 6
antineutrophil cytoplasmic antibodies (5) 5
biomarkers (5) 5
immunology (5) 5
patients (5) 5
relapse (5) 5
rituximab - therapeutic use (5) 5
severity of illness index (5) 5
anca-associated vasculitis (4) 4
anti-neutrophil cytoplasmic antibody-associated vasculitis - blood (4) 4
antibodies, monoclonal, murine-derived - therapeutic use (4) 4
azathioprine - therapeutic use (4) 4
biomarkers - blood (4) 4
clinical trials (4) 4
cyclophosphamide (4) 4
disease (4) 4
drug therapy, combination (4) 4
immunosuppressive agents - therapeutic use (4) 4
maintenance (4) 4
medical treatment (4) 4
medicine, general & internal (4) 4
microscopic polyangiitis (4) 4
prospective studies (4) 4
recurrence (4) 4
animals (3) 3
anti-neutrophil cytoplasmic antibody-associated vasculitis - immunology (3) 3
anti-neutrophil cytoplasmic antibody-associated vasculitis - pathology (3) 3
antibodies, antineutrophil cytoplasmic - blood (3) 3
antibody-associated vasculitis (3) 3
cytokines (3) 3
dap12-deficient mice (3) 3
genotype & phenotype (3) 3
glucocorticoids - therapeutic use (3) 3
granulomatosis with polyangiitis - drug therapy (3) 3
liver (3) 3
lymphocytes b (3) 3
mice (3) 3
myeloblastin - immunology (3) 3
neutrophils (3) 3
patient outcomes (3) 3
pediatrics (3) 3
systemic vasculitides (3) 3
treatment resistance (3) 3
usage (3) 3
adaptor proteins, signal transducing - deficiency (2) 2
adaptor proteins, signal transducing - genetics (2) 2
allergies (2) 2
anca (2) 2
anti-neutrophil cytoplasmic antibody-associated vasculitis - diagnosis (2) 2
antibodies, antineutrophil cytoplasmic (2) 2
antineutrophil cytoplasmic antibody (2) 2
antirheumatic agents - therapeutic use (2) 2
arthritis (2) 2
autoantibodies (2) 2
autoimmune diseases (2) 2
azathioprine (2) 2
b cells (2) 2
b-lymphocytes - immunology (2) 2
bioindicators (2) 2
c-reactive protein (2) 2
care and treatment (2) 2
cell-activation (2) 2
child (2) 2
child, preschool (2) 2
chimerism (2) 2
classification (2) 2
cohort studies (2) 2
comparative analysis (2) 2
cutting edge (2) 2
cyclophosphamide - adverse effects (2) 2
cytochrome (2) 2
disease progression (2) 2
disease-activity (2) 2
drug therapy (2) 2
e-selectin (2) 2
enzymes (2) 2
expression (2) 2
flow cytometry (2) 2
follow-up (2) 2
glomerular filtration rate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB385 - AB385
  Methods Post-hoc correlation of response to out of season nasal allergen challenge TNSS and seasonal outcomes including weekly visual analogue score (VAS),... 
Allergy and Immunology | Immunotherapy | Pollen | Seasons | Allergies
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 221 - 232
Journal Article
Journal Article
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue 6, pp. 1166 - 1169
Journal Article
Nature Immunology, ISSN 1529-2908, 02/2009, Volume 10, Issue 2, pp. 223 - 223
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2016, Volume 68, Issue 12, pp. 2945 - 2952
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 07/2016, Volume 68, Issue 7, pp. 1700 - 1710
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 07/2015, Volume 67, Issue 7, pp. 1922 - 1932
Journal Article